Usefulness of Biparametric Magnetic Resonance Imaging Combined With Prostate Specific Antigen Density in Pre-biopsy Detection of Clinically Insignificant Prostate Cancer | Anticancer Research
Adult Urology | Journal of Urology
Defining clinically significant prostate cancer on the basis of pathological findings - Matoso - 2019 - Histopathology - Wiley Online Library
UCSF ci2 and DAIR Collaborate to Improve Detection of Clinically Significant Prostate Cancer from Prostate MRI | Center for Intelligent Imaging | UCSF Radiology
Efficacy of 3T Multiparametric MR Imaging followed by 3T in-Bore MR-Guided Biopsy for Detection of Clinically Significant Prostate Cancer Based on PIRADSv2.1 Score - Journal of Vascular and Interventional Radiology
A combinatorial neural network analysis reveals a synergistic behaviour of multiparametric magnetic resonance and prostate health index in the identification of clinically significant prostate cancer - Clinical Genitourinary Cancer
Comparison of single-scanner single-protocol quantitative ADC measurements to ADC ratios to detect clinically significant prostate cancer - European Journal of Radiology
Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 4: Transperineal Magnetic Resonance–Ultrasound Fusion Guided Biopsy Using Local Anesthesia - European Urology
The effect of 5 alpha-reductase inhibitor therapy on prostate cancer detection in the era of multi-parametric magnetic resonance imaging | Scientific Reports
SciELO - Brasil - Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical prostatectomy Undergrading and understaging in patients with clinically insignificant prostate cancer who underwent radical ...
The Radiology Assistant : Prostate Cancer - PI-RADS v2
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis | NEJM
Biparametric prostate MRI and clinical indicators predict clinically significant prostate cancer in men with “gray zone” PSA levels - European Journal of Radiology
Article of the Week: Prostate Health Index density improves detection of clinically significant prostate cancer - BJUI
PLOS ONE: Diagnostic value and relative weight of sequence-specific magnetic resonance features in characterizing clinically significant prostate cancers
Fast' MRI shows potential as prostate cancer screening method
Fourteen-Core Systematic Biopsy That Includes Two Anterior Cores in Men With PI-RADS Lesion ≥ 3 is Comparable With Magnetic Resonance Imaging-ultrasound Fusion Biopsy in Detecting Clinically Significant Prostate Cancer: A Single-institution Experience -
Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer | Radiology
SciELO - Brasil - The accuracy of pathological data for the prediction of insignificant prostate cancer The accuracy of pathological data for the prediction of insignificant prostate cancer
Definitions for clinically non-significant prostate cancer. | Download Table
68Ga PSMA-11 PET/CT increases specificity for detection of clinically significant prostate cancer of lesions at multiparametric prostate MRI. | Journal of Nuclear Medicine
